ACTRN12607000229471
Not yet recruiting
Phase 2
Participant: Individuals with osteoarthritisIntervention: Seaweed extractOutcome: Comprehensive Osteoarthritis testComparator:Dose comparison
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Osteoarthritis
- Sponsor
- Marinova Pty Ltd
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •X\-ray and clinical evidence of osteoarthritis of the kneesIn good general healthAdequate venous accessParticipants willing to discontinue their current OA (osteoarthritis) treatment for the duration of the study. This includes treatment with intra\-articular injections, corticosteroids, NSAIDs (non steroidal anti inflammatory drug), non\-prescription therapies, chondroprotective agents, occlusive dressings, physiotherapy, or orthopaedic technical measuresParticipants of childbearing age who agree to continue using birth control measures for the duration of the study.
Exclusion Criteria
- •A history of trauma associated with the affected jointRheumatoid or other inflammatory joint conditionsGoutUse of corticosteroids (intra\-articular or systematic) within 4 weeks prior to baseline and throughout the studyUse of anti\-inflammatory agents or anti\-arthritic complementary medicines 3 weeks prior to baseline and for the duration of the studyLiver function tests greater than 3 times the upper limit of normal at baselineHistory of alcohol or substance abuseFemale participants who are lactating, pregnant or planning to become pregnantParticipants who have participated in another clinical trial in the last 30 daysParticipants unwilling to comply with the study protocolAny other condition, which in the opinion of the investigators could compromise the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A double-blind cross-over placebo controlled study of Evogen® Topical gel in the treatment of mild to moderate pain associated with osteoarthritisACTRN12607000226404Blackmore's Pty Ltd20
Active, not recruiting
Phase 4
The long-term evaluation of glucosamine sulphate (LEGS) studyOsteoarthritis kneeMusculoskeletal - OsteoarthritisACTRN12607000433404Clinical and Rehabilitation Sciences Research Group, Faculty of Health Sciences600
Completed
Not Applicable
Prospective clinical study using X-ray to evaluate fixation of cementless total knee replacement componentsACTRN12609000514202Stryker Australia20
Completed
Not Applicable
A prospective, observational, cohort study of the MASTER-SL Femoral stem in patients with degenerative disease of the hipOsteoarthritisMusculoskeletal - OsteoarthritisACTRN12617000550303The Orthopaedic Institute of Queensland (ORIQL)50
Completed
Not Applicable
The effectiveness of intra-articular hyaluronan (Synvisc®) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot (hallux limitus)ACTRN12607000654459a Trobe University150